Entries by Alex Scott-Simons

Enhanc3D Genomics appoints Hazel Jones as Chief Executive Officer

Cambridge, UK, 15 May 2024: Enhanc3D Genomics, a company developing disruptive technologies to unlock the 3D genome for use in novel target identification and unique patient stratification, today announced the appointment of Hazel Jones as Chief Executive Officer, after a successful six-month tenure as interim CEO and COO.   As COO and interim CEO Hazel has […]

Enhanc3D Genomics raises £10 million in Series A financing to advance GenLink3D proprietary technology platform

GenLink3DTM provides the first high-resolution mapping of DNA interactions in 3D space, enabling the vast array of non-coding genetic variations to be deciphered into actionable disease biomarkers and treatment targets Funds will be used to rapidly generate deep datasets of novel diagnostic signatures and candidate therapeutic targets across multiple immune-related diseases for internal and external […]